Another weekend of NFL action is mostly in the books and we’re just one primetime game away from being officially at the halfway point of the 2025 regular season. We still have the Monday night ...

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...

The decision to award former UN human rights chief Navi Pillay the 2025 Sydney Peace Prize has drawn fierce criticism from Jewish leaders, human rights monitors and other officials who accuse her of ...